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Abstract
Background: Nearly 3,000 plant species are used as medicines in South Africa, with approximately 350 species
forming the most commonly traded and used medicinal plants. In the present study, twelve South African
medicinal plants were selected and tested for their antimicrobial activities against eight microbial species belonging
to fungi, Mycobacteria, Gram-positive and Gram-negative bacteria.
Methods: The radiometric respiratory technique using the BACTEC 460 system was used for susceptibility testing
against Mycobacterium tuberculosis, and the liquid micro-broth dilution was used for other antimicrobial assays.
Results: The results of the minimal inhibitory concentration (MIC) determinations indicated that the methanol
extracts from Acacia karoo, Erythrophleum lasianthum and Salvia africana were able to prevent the growth of all the
tested microorganisms. All other samples showed selective activities. MIC values below 100 μg/ml were recorded
with A. karoo, C. dentate, E. lasianthum, P. obligun and S. africana on at least one of the nine tested microorganisms.
The best activity (MIC value of 39.06 μg/ml) was noted with S. africana against E. coli, S. aureus and M. audouinii,
and Knowltonia vesitoria against M. tuberculosis.
Conclusion: The overall results of the present work provide baseline information for the possible use of the studied
South African plant extracts in the treatment of microbial infections.
Background
The World Health Organization (WHO) estimates that
up to 80% of the population in Africa makes use of
traditional medicine as well as about 65% of the world's
population [1]. Plants used in traditional medicine, also
called phytomedicine are plant-derived medicines that
contain chemicals, more usually, mixtures of chemical
compounds that act individually or in combination on
the human body to prevent disorders and to restore or
maintain health [2]. With up to 19,581 indigenous spe-
cies, South Africa has the richest temperate flora in the
world. A minimum of 11,700 species are endemic to
South Africa [3] and nearly 3,000 species are used as
medicines with approximately 350 species forming the
most commonly traded and used medicinal plants
[4]. Hence, there is good reason to screen these
traditionally used plants for new drug discovery. The
ethnobotanical approach has a number of advantages
when searching for new drug candidates. The plants
have been ‘pre-screened’ through generations of trial
and error processes occurring over hundreds or thou-
sands of years [5]. This will result in a higher probabil-
ity of producing useful therapies from a group of
medicinal plants, and one can rationalize that any iso-
lated active compounds from plants are likely to be
safer than active compounds from plants with no his-
tory of human use [5,6]. The present work was there-
fore designed to investigate the antimicrobial activity of
twelve selected South African medicinal plants, Acacia
karroo Hayne (Mimosoideae), Acokanthera oppositifolia
(Lam.) Codd (Apocynaceae), Bulbine latifolia (L.f.)
Spreng var. Latifolia (Asphodelaceae), Curtisia dentata
(Burm.f.) C.A.Sm. (Cornaceae), Erythrophleum
lasianthum Corbishley (Caesalpinioideae), Knowltonia
vesicatoria Sims (Ranunculaceae), Ptaeroxylon obliquum
(Thunb.) Radlk. (Ptaeroxylaceae), Salvia africana-lutea
L. (Lamiaceae), Sansevieria hyacinthoides Hort. ex
Steud. (Dracaenaceae).
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Methods
Plant materials and extraction
All plants were collected on the Campus area of the
University of Pretoria in August 2007. The plant parts
were mainly aerial parts such as leaves, stems and flow-
ers, except for S. hyacinthoides where the rhizome was
dug up and collected, based on the traditional uses
(Table 1). The plants were then identified at the HGWJ
Schweicherdt Herbarium, University of Pretoria and a
voucher specimen was preserved there as well (Table 1).
The air dried and powdered sample from each plant
(10 g) were macerated in methanol (300 ml) for 48 h at
room temperature with occasional shaking. After 48
hours the extract was filtered through a Whatmann no.
1 filter paper. The extract was then concentrated under
reduced pressure to give the crude extracts. They were
then kept at 4 °C until further use.
Chemicals for antimicrobial assay
Nystatin (Maneesh Pharmaceutic PVT) for fungi, cipro-
floxacin and isoniazid (INH) (Sigma-Aldrich, Johannes-
burg, South Africa) for Mycobacterium smegmatis and
M. tuberculosis respectively and gentamicin (Jinling
Pharmaceutic Group corp.) for other bacteria were used
as reference antibiotics (RA).
Microorganisms and culture media
The tested organisms included Mycobacterium smegma-
tis ATCC 700084 [obtained from South African Medical
Research Council, Pretoria and authenticated by Profes-
sor Fanus Venter, Department of Microbiology and
Plants Pathology, University of Pretoria], drug-
susceptible strain of Mycobacterium tuberculosis H37Rv
ATCC 27294 (America Type Culture Collection, Rock-
ville, MD, USA), Methicillin-resistant Staphylococcus
Table 1 Plants used in the present work
Botanical name (FAMILY) voucher specimen Parts used, extraction yield Traditional use
Acacia karroo HayneA (Mimosoideae) T. Nielsen PRU 096395 Leaves, 25.1% Stem+Bark, 13.6% Mouth ulcers, oral thrushE, diarrhea,
dysenteries, colic, coldsG, other
Acacia species: asthma, bronchitis,




T. Nielsen PRU 0963388 Leaves, 27.7% Stem, 12.6% Hunting poisonF, snakebitesD, abnormal
menstruation, snuff for headaches,
septicaemia, toothacheE.
Bulbine latifolia (L.f.) Spreng var.
latifoliaA (Asphodelaceae)
T. Nielsen PRU 096391 Leaves, 0.5% Wounds, burns, skin conditionsE, diarrhoea,
dysenteries, abdominal ailmentsG, rheumatismH.
Curtisia dentata (Burm.f.) C.A.Sm.A
(Cornaceae)
T. Nielsen PRU 096385 Leaves, 33.7% Stem, 15.1% Stomach ailments, diarrhea, blood purifier,





Leaves, 41.2% Stem, 31.2% HeadachesD, feverH, Erythrophleum species:
heart problem, dermatitis, wounds, rheumatism,
syphilis, gonorrhea, leprosy, tuberculosis,
bronchitis, angina, ordeal and hunting poisonF.
Knowltonia vesicatoria SimsB
(Ranunculaceae)




T. Nielsen PRU 096389 Leaves, 23.1%, Stem, 16.1%,
Bark, 13.7%
Snuff for headachesD, rheumatism, arthritisE,
heart disease, anthrax, sinusitis, lupus, wartsG,
sternutatoryH.
Salvia africana-lutea L.A (Lamiaceae) T. Nielsen PRU 096396 Aerial parts, 29.2% Colds, flu, bronchitis, abdominal and uterine
troublesE, cough, chest troublesG, other Salvia
species: night sweat tuberculosis, respiratory and
pulmonary ailments, G,H .
Sansevieria hyacinthoides Hort. ex
Steud.B (Dracaenaceae)
T. Nielsen PRU 0963387 Leaves, 11.9% Rhizome, 12.7% Earache, stomachache, toothache, hemorrhoids,
ulcers, diarrhea, intestinal parasitesE, Sansevieria
species: chest diseases, cough remedyF.
Searsia burchellii (Sond. ex Engl.)
MoffettC (Anarcardiaceae)
T. Nielsen PRU 096386 Leaves, 24.5% Stem, 9.4% Chest coldsG, Rhus (Searsia) species: colds, cough,
expectorant, febrifuge, pulmonary ailments,
tuberculosisH.
Typha capensis Rohrb.B (Typhaceae) T. Nielsen PRU 096394 Leaves, 17.0% Fertility, potency, circulation, delivery, venereal
diseases, dysentery, diarrhea, enteritis, blood
purifierE, gonorrhea, pulmonary ailmentsH.
Zantedeschia aethiopica (L.)
Spreng.A (Araceae)
T. Nielsen PRU 096392 Leaves + Stem, 15.2% Wounds, sores, boilsE,G, insect bites, gout,
rheumatismG,H.
A: A checklist of South African plants [3]; B: The International Plants Names Index [7] C: Moffett [8]; D: Trees of Southern Africa [9]; E: People’s Plants [2], F: African
Ethnobotany [10]; G: The Medicinal and Poisonous Plants of Southern and Eastern Africa [11]; H: CRC Ethnobotany Desk Reference [12].
* No reproductive parts (flowers, fruits) could be collected from this plant; consequently no herbarium specimen is available.
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aureus (MRSA, LMP805) (Gram-positive bacterium),
four Gram-negative bacteria namely β-lactamase positive
(βL+) Escherichia coli (βL+EC, LMP701), Ampicillin-
resistant Klebsiella pneumoniae (ARKP, LMP803),
Carbenicillin-resistant Pseudomonas aeruginosa (CRPA,
LMP804), Chloramphenicol-resistant Citrobacter (CRCF,
LMP802) and two fungi namely Candida albicans (C.
albicans LMP709U) and Microsporum audouinii (M.
audouinii, LMP725D). M. smegmatis was cultured on
Middlebrook 7 H11 agar and allowed to grow for 24 h.
M. tuberculosis was plated on Löwenstein–Jensen
medium and allowed to grow for 3–4 weeks at 37 °C.
The 7 H9 broth was used to determine the minimal in-
hibition concentration (MIC) of the test samples on M.
smegmatis and M. tuberculosis. Other microbial species
were clinical isolates from Yaoundé General Hospital
(Cameroon). Their identity was confirmed before use at
the Laboratory of Applied Microbiology and Molecular
Pharmacology (LMP) (Faculty of Science, University of
Yaoundé I) by culturing on the specific media followed
by biochemical test using API system as previously
reported [13]. All the studied microorganisms were
maintained on agar slant at 4 °C at the LMP. These
strains were sub-cultured on a fresh appropriate agar
plate 24 hours prior to any antimicrobial test. The Muel-
ler Hinton broth (MHB) was used to determine the MIC
of all samples against the tested pathogens. The MHB
and Mueller Hinton Agar (MHA) were used to deter-
mine the minimal microbicidal concentration (MMC) of
the active samples.
Microplate susceptibility testing against M. Smegmatis
All extracts were tested against M. smegmatis using the
microplate dilution method. The MIC, MBC and bac-
teria preparation were performed in 96-well microplates
as previously described [14,15]. The crude extracts were
dissolved in 10% dimethylsulfoxide (DMSO) in sterile
7 H9 broth to obtain a stock concentration of 10 mg/
ml. Serial two-fold dilutions of each sample to be evalu-
ated were made with 7 H9 broth to yield volumes of
100 μl/well with final concentrations ranging from
19.53–2500 μg/ml. Ciprofloxacin served as the positive
drug control. One hundred microlitre of M. smegmatis
(0.2 log-phase, yielding 1.5 × 106 CFU/ml) were also
added to each well containing the samples. The solvent
control, DMSO at 2.5% or less in each well did not
show inhibitory effects on the growth of M. smegmatis.
Tests were done in triplicates. The cultured microplates
were sealed with parafilm and incubated at 37 °C for
24 h. The MIC was detected following addition (40 μl)
of 0.2 mg/ml p-iodonitrotetrazolium chloride (INT,
Sigma-Aldrich) and incubated at 37 °C for 30 min
[16,17]. Viable bacteria reduced the yellow dye to a
pink color. MIC was defined as the lowest sample
concentration that prevented this change and exhibited
complete inhibition of bacterial growth. The MBC was
determined by adding 50 μl aliquots of the preparations
(without INT), which did not show any growth after in-
cubation during MIC assays, to 150 μl of 7 H9 broth.
These preparations were incubated at 37 °C for 48 h.
The MBC was regarded as the lowest concentration of
extract, which did not produce a color change after
addition of INT as above mentioned.
Antitubercular rapid radiometric assay using
mycobacterium tuberculosis
The radiometric respiratory technique using the BAC-
TEC 460 system (Becton Dickinson Diagnostic Instru-
ment, Sparks, MD) was used for susceptibility testing
against M . tuberculosis as described previously [17-19]
with some modifications. Solutions of all the samples
were prepared in Dimethylsulfoxide (DMSO) to obtain
a stock concentration. Control experiments showed that
a final concentration of DMSO at 1% in the medium
had no adverse effect on the growth of M. tuberculosis.
The primary drug INH served as drug-control. A
homogenous culture (0.1 ml of M. tuberculosis, yielding
1 × 104 to 1 × 105 CFU/ml) was inoculated in the vials
containing samples as well as control vials [20]. Three
sample-free vials were used as controls (medium+ 1%
DMSO); two vials (V1) were inoculated in the same
way as the vials containing the sample, and one (V2)
was inoculated with a 1:100 dilution of the inoculum
(1:100 control) to produce an initial concentration
representing 1% of the bacterial population (1 × 102 to
1 × 103 CFU/ml). Mycobacterium growing in 7 H12
medium containing 14 C labeled substrate (palmitic
acid) uses the substrate and produced 14CO2. The
amount of 14CO2 detected is expressed in terms of the
growth index (GI) [21]. Vials were incubated at 37 °C
and each was assayed everyday to measure the GI. On
the Bactec TB-460 system, the GI is recorded on a scale
of 0–999. Growth is detected when GI ≥ 20. Then the
GI value of 10 represents the growth of 1% of the bac-
terial population, once the inoculum control reach 999.
Therefore, the MIC was considered as the lowest con-
centration inhibiting more than 99% of the initial bac-
terial population. This was taken as the lowest
concentration of the sample with recorded ΔG< 10.
ΔG=Gx−G0; Gx being the GI of the treated medium
on the day that control inoculum vial reach 999, G0
the GI at the first day of reading and ΔG, the difference
between Gx and G0 [22].
Antimicrobial assay on gram-positive, gram-negative
bacteria and fungi
The MICs of crude extracts and reference antibiotics
(RA) (gentamicin for bacteria and nystatin for fungi)
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were determined as follows: the test sample was first of
all dissolved in dimethylsulfoxide (DMSO). The solution
obtained was added to MHB to give a final concentra-
tion of 2500 μg/ml for the crude extracts and 78.12 for
RA. This was serially diluted two fold to obtain concen-
tration ranges of 19.53 to 2500 μg/ml for the crude
extracts and 0.31 to 78.12 μg/ml for RA. One hundred
microlitre of each concentration were added to each well
(96- wells microplate) containing 95 μl of NBGP and
5 μl of inoculum (standardized at 1.5 106 CFU/ml by
adjusting the optical density to 0.1 at 600 nm SHI-
MADZU UV-120-01 spectrophotometer) [23,24]. The
final concentration of DMSO in the well was less than
1% (preliminary analyses with 1% (v/v) DMSO do not
affect the growth of the test organisms). The negative
control well consisted of 195 μl of MHB and 5 μl of the
standard inoculum [23,24]. The plates were covered with
a sterile plate sealer, then agitated to mix the contents of
the wells using a plate shaker and incubated at 37 °C for
24 hours. The assay was repeated thrice. The effect of
samples was detected following addition (40 μl) of
0.2 mg/ml p-iodonitrotetrazolium chloride and incu-
bated at 37 °C for 30 min [25]. MIC and MMC were
determined as above [23,24].
Results and discussion
The results of the antimicrobial activity of the studied
plant extracts are summarized in Table 2 and 3. The
results of the MIC determinations (Table 2) showed that
the extracts from A. karoo, E. lasianthum stem and S. af-
ricana were able to prevent the growth of all the tested
microorganisms. All other samples showed selective ac-
tivities. Phytochemicals are routinely classified as antimi-
crobials on the basis of susceptibility tests that produce
MIC in the range of 100 to 1000 μg/ml [25]. Activity is
considered to be significant if MIC values are below
100 μg/ml for crude extract and moderate when 100<
MIC< 625 μg/ml [26,27]. Therefore, the activity
Table 2 Minimal inhibition concentration (μg/ml) of the crude extracts and reference antibiotics
Tested samples Tested microorganisms*
Bacteria Fungi Mycobacteria
βL+EC CRCF ARKP CRPA MRSA C. albicans M. audouinii M. smegmatis M. tuberculosis
A. oppositifolia leaves 2500 1250 625 625 312.50 312.50 >2500 >2500 nt
A. oppositifolia stem 2500 >2500 >2500 312.50 312.50 312.50 312.50 >2500 nt
A. karoo leaves 156.25 312.50 156.25 156.25 156.25 78.12 625 1250 nt
A. karoo stem 156.25 312.50 78.12 156.25 78.12 156.25 78.12 1250 2500
B. latifolia leaves 2500 2500 >2500 625 1250 625 312.50 >2500 nt
C. dentata stem bark 156.25 156.25 156.25 156.25 156.25 78.12 1250 1250 nt
C. dentate leaves 1250 625 312.50 312.50 78.12 78.12 >2500 1250 nt
E. lasianthum leaves 1250 312.50 156.25 625 312.50 312.50 312.50 >2500 nt
E. lasianthum stem 156.25 312.50 312.50 156.25 39.06 78.12 312.50 1250 625
K. vesitoria aerial part 2500 2500 >2500 625 >2500 312.50 156.25 1250 39.06
P. obligum leaves 625 312.50 312.50 156.25 625 156.25 >2500 >2500 nt
P. obligun stem 625 >2500 >2500 312.50 156.25 312.50 312.50 >2500 nt
P. obligun bark 78.12 >2500 >2500 >2500 156.25 156.25 78.12 156.25 156.25
S. burchellii leaves 312.50 625 156.25 625 312.50 312.50 156.25 >2500 312.50
S. burchellii bark 156.25 312.50 156.25 156.25 156.25 156.25 156.25 >2500 nt
S. hyacithoides leaf 625 1250 1250 312.50 >2500 312.50 312.50 >2500 nt
S. hyacithoides Rhizoma 625 312.50 625 >2500 >2500 156.25 156.25 >2500 nt
S. africana aerial part 39.06 312.50 312.50 156.25 39.06 156.25 39.06 312.50 312.50
T. capensis aerial part 625 >2500 312.50 625 625 312.50 312.50 >2500 nt
Z. aethiopica leaves and stem 625 >2500 >2500 312.50 >2500 312.50 312.50 >2500 nt
Gentamicin 9.76 9.76 19.53 19.53 9.76 nt nt nt nt
Nystatin nt nt nt nt nt 19.53 19.53 nt nt
Ciprofloxacin nt nt nt nt nt nt nt 0.3 nt
isoniazid nt nt nt nt nt nt nt nt 0.13
*The tested microorganisms are MRSA (Methicillin-resistant Staphylococcus aureus), βL+EC (β-lactamase positive Escherichia coli), ARKP (Ampicillin-resistant
Klebsiella pneumoniae), CRPA (Carbenicillin-resistant Pseudomonas aeruginosa), CRCF (Chloramphenicol-resistant Citrobacter), C. albicans (Candida albicans), M.
audouinii (Microsporum audouinii); (nt): not tested.
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recorded with A. karoo (leaves extract on C. albicans, M.
audouinii and stem extract on M. audouinii and K.
pneumoniae), C. dentate (leaves extract on C. albicans
and stem bark extract on C. albicans and S. aureus), E.
lasianthum on S. aureus, P. obligun bark on E. coli and
M. audouinii, S. africana on E. coli, S. aureus and M.
audouinii and K. vesitoria aerial part on M. tuberculosis
can be considered significant. The best activity was
noted with S. africana, with the lowest MIC value of
39.06 μg/ml recorded on three of the nine microorgan-
isms studied. Eight plant extracts found active against
M. smegmatis were tested against M. tuberculosis
(Table 2). Interestingly, they were also found to be active
against M. tuberculosis, the best sample being the extract
the aerial part of K. vesitoria (MIC of 39.06 μg/ml) and
that from the bark of P. obligun (MIC of 156.25 μg/ml).
However, it has been demonstrated that the sensitivity of
M. tuberculosis is closer to that of M. smegmatis, a non
pathogenic microorganism [15]. Therefore, this micro-
organism can be used for a preliminary study to select
samples with potential activity against M. tuberculosis
[15]. Hence, the results obtained herein are in accord-
ance with such recommendation. Alternative criteria
have been described by Fabry et al. [28], which consider
extracts having MIC values below 8 mg/ml to have note-
worthy antimicrobial activity. Under these less stringent
criteria, the overall activity recorded with most of the
studied extracts can be considered important. However,
the tested samples were less active than the RA on all of
the microbial strains, this observation been quite normal
as it is expected that a crude extract (that contained a
panel of both active and non active molecules) shows
less activity than a purified compound. The results of
the MMC determinations (Table 3) also showed that
microbicidal effect of most of the active samples could
be expected. The lowest MMC value below 100 μg/ml
was recorded with S. africana, highlighting the good
antimicrobial potency of this plant.
The results of the present work can be considered im-
portant with regards to the medical importance of the
studied microorganisms and the fact that most of them
were found to be resistant to commonly used antibiotics.
Table 3 Minimal microbicdal concentration (μg/ml) of the crude extracts and reference antibiotics
Tested samples Tested microorganisms*
Bacteria Fungi Mycobacteria
βL+EC CRCF ARKP CRPA MRSA C. albicans M. audouinii M. smegmatis
A. oppositifolia leaves >2500 2500 1250 1250 625 625 nd >2500
A. oppositifolia stem >2500 nd nd 1250 625 625 1250 >2500
A. karoo leaves 312.50 625 312.50 1250 312.50 312.50 1250 >2500
A. karoo stem 625 625 312.50 312.50 156.25 312.50 312.50 >2500
B. latifolia leaves >2500 >2500 nd 1250 2500 1250 625 >2500
C. dentata stem bark 312.50 625 312.50 312.50 312.50 312.50 >2500 >2500
C. dentate leaves >2500 2500 625 1250 156.25 156.25 nd >2500
E. lasianthum leaves 2500 625 312.50 1250 625 625 625 >2500
E. lasianthum stem 625 625 625 312.50 78.12 312.50 625 >2500
K. vesitoria aerial part >2500 >2500 nd 1250 nd 625 312.50 2500
P. obligum leaves 1250 1250 1250 625 1250 312.50 nd >2500
P. obligun stem 1250 nd nd 625 312.50 625 625 2500
P. obligun bark 312.50 nd nd nd 625 312.50 312.50 >2500
S. burchellii leaves 625 1250 312.50 1250 625 625 312.50 >2500
S. burchellii bark 312.50 625 312.50 312.50 312.50 312.50 312.50 >2500
S. hyacithoides leaf 1250 2500 2500 1250 nd 625 625 >2500
S. hyacithoides Rhizoma 1250 1250 1250 nd nd 625 625 >2500
S. fricana aerial part 78.12 625 625 312.50 78.12 312.50 78.12 2500
T. capensis aerial part 2500 nd 1250 1250 1250 1250 625 >2500
Z. aethiopica leaves and stem 2500 nd nd 2500 nd 1250 625 >2500
Gentamicin 19.53 19.53 39.06 39.06 19.53 nt nt nt
Nystatin nt nt nt nt nt 39.06 39.06 nt
Ciprofloxacin nt nt nt nt nt nt nt 0.3
*The tested microorganisms are MRSA (Methicillin-resistant Staphylococcus aureus), βL+EC (β-lactamase positive Escherichia coli), ARKP (Ampicillin-resistant
Klebsiella pneumoniae), CRPA (Carbenicillin-resistant Pseudomonas aeruginosa), CRCF (Chloramphenicol-resistant Citrobacter), C. albicans (Candida albicans), M.
audouinii (Microsporum audouinii); (nt): not tested; (nd): not determined as the MIC was >2500 μg/ml.
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P. aeruginosa is an important nosocomial pathogen highly
resistant to clinically used antibiotics, causing a wide
spectrum of infections and leading to substantial morbid-
ity and mortality [29]. Drug-resistant Enterobacteriaceae,
including K. pneumoniae, E. aerogenes and E. coli, have
also been classified as antimicrobial-resistant organisms of
concern in healthcare facilities [30]. The activity of some
of the extracts on M. smegmatis also suggested that an in-
hibition effect of this plant on M. tuberculosis could be
expected as the sensitivity of this microbial species was
found to be closer to M. smegmatis, a non pathogenic
agent [15], and this hypothesis was confirmed herein.
Conclusion
The overall results of the present work provide baseline
information for the possible use of South African plant
extracts in the treatment of microbial infections involv-
ing resistant phenotypes.
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